These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17391962)

  • 1. Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.
    Deskus JA; Epperson JR; Sloan CP; Cipollina JA; Dextraze P; Qian-Cutrone J; Gao Q; Ma B; Beno BR; Mattson GK; Molski TF; Krause RG; Taber MT; Lodge NJ; Mattson RJ
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3099-104. PubMed ID: 17391962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.
    Mattson RJ; Catt JD; Denhart DJ; Deskus JA; Ditta JL; Higgins MA; Marcin LR; Sloan CP; Beno BR; Gao Q; Cunningham MA; Mattson GK; Molski TF; Taber MT; Lodge NJ
    J Med Chem; 2005 Sep; 48(19):6023-34. PubMed ID: 16162005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitors.
    King HD; Meng Z; Deskus JA; Sloan CP; Gao Q; Beno BR; Kozlowski ES; Lapaglia MA; Mattson GK; Molski TF; Taber MT; Lodge NJ; Mattson RJ; Macor JE
    J Med Chem; 2010 Nov; 53(21):7564-72. PubMed ID: 20949929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homotryptamines as potent and selective serotonin reuptake inhibitors (SSRIs).
    Schmitz WD; Denhart DJ; Brenner AB; Ditta JL; Mattson RJ; Mattson GK; Molski TF; Macor JE
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1619-21. PubMed ID: 15745809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformationally restricted homotryptamines. Part 6: indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.
    Ditta JL; Denhart DJ; Deskus JA; Epperson JR; Meng Z; Gao Q; Mattson GK; Lapaglia MA; Taber MT; Molski TF; Lodge NJ; Mattson RJ; Macor JE
    Bioorg Med Chem Lett; 2013 May; 23(10):2948-50. PubMed ID: 23578689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.
    Dalton King H; Denhart DJ; Deskus JA; Ditta JL; Epperson JR; Higgins MA; Kung JE; Marcin LR; Sloan CP; Mattson GK; Molski TF; Krause RG; Bertekap RL; Lodge NJ; Mattson RJ; Macor JE
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5647-51. PubMed ID: 17766113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors.
    Denhart DJ; Deskus JA; Ditta JL; Gao Q; Dalton King H; Kozlowski ES; Meng Z; LaPaglia MA; Mattson GK; Molski TF; Taber MT; Lodge NJ; Mattson RJ; Macor JE
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4031-3. PubMed ID: 19560923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
    Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
    J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands - Fluoxetine and fluvoxamine.
    Staroń J; Pietruś W; Bugno R; Kurczab R; Satała G; Warszycki D; Lenda T; Wantuch A; Hogendorf AS; Hogendorf A; Duszyńska B; Bojarski AJ
    Eur J Med Chem; 2021 Aug; 220():113533. PubMed ID: 34049262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
    Cozzi NV; Gopalakrishnan A; Anderson LL; Feih JT; Shulgin AT; Daley PF; Ruoho AE
    J Neural Transm (Vienna); 2009 Dec; 116(12):1591-9. PubMed ID: 19756361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological screening of novel indolalkyl arenes targeting the serotonine transporter.
    Ojeda-Gómez C; Pessoa-Mahana H; Iturriaga-Vásquez P; Pessoa-Mahana CD; Recabarren-Gajardo G; Méndez-Rojas C
    Arch Pharm (Weinheim); 2014 Mar; 347(3):174-84. PubMed ID: 24339227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
    Hatzenbuhler NT; Evrard DA; Harrison BL; Huryn D; Inghrim J; Kraml C; Mattes JF; Mewshaw RE; Zhou D; Hornby G; Lin Q; Smith DL; Sullivan KM; Schechter LE; Beyer CE; Andree TH
    J Med Chem; 2006 Jul; 49(15):4785-9. PubMed ID: 16854086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of the serotonin transporter protein (SERT): the design and synthesis of biotinylated derivatives of 3-(1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indoles. High-affinity serotonergic ligands for conjugation with quantum dots.
    Tomlinson ID; Mason JN; Blakely RD; Rosenthal SJ
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5307-10. PubMed ID: 16183285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for selective serotonin reuptake inhibition by the antidepressant agent fluoxetine (Prozac).
    Andersen J; Stuhr-Hansen N; Zachariassen LG; Koldsø H; Schiøtt B; Strømgaard K; Kristensen AS
    Mol Pharmacol; 2014 May; 85(5):703-14. PubMed ID: 24516100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.
    Mahaney PE; Kim CY; Coghlan RD; Cohn ST; Heffernan GD; Huselton CA; Terefenko EA; Vu AT; Zhang P; Burroughs KD; Cosmi SA; Bray JA; Johnston GH; Deecher DC; Trybulski EJ
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5807-10. PubMed ID: 19713106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand conformation has a definitive effect on 5-HT1A and serotonin reuptake affinity.
    Boy KM; Dee M; Yevich J; Torrente J; Gao Q; Iben L; Stark A; Mattson RJ
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4467-70. PubMed ID: 15357973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
    Orjales A; Mosquera R; Toledo A; Pumar MC; García N; Cortizo L; Labeaga L; Innerárity A
    J Med Chem; 2003 Dec; 46(25):5512-32. PubMed ID: 14640559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New indole derivatives as potent and selective serotonin uptake inhibitors.
    Malleron JL; Guérémy C; Mignani S; Peyronel JF; Truchon A; Blanchard JC; Doble A; Laduron P; Piot O; Zundel JL
    J Med Chem; 1993 Apr; 36(9):1194-202. PubMed ID: 8487257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants.
    Matzen L; van Amsterdam C; Rautenberg W; Greiner HE; Harting J; Seyfried CA; Böttcher H
    J Med Chem; 2000 Mar; 43(6):1149-57. PubMed ID: 10737747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel pyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT
    Ślifirski G; Król M; Kleps J; Ulenberg S; Belka M; Bączek T; Siwek A; Stachowicz K; Szewczyk B; Nowak G; Bojarski A; Kozioł AE; Turło J; Herold F
    Eur J Med Chem; 2019 Mar; 166():144-158. PubMed ID: 30703658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.